for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BACHEM HOLDING AG

BANB.S

Latest Trade

146.00CHF

Change

1.00(+0.69%)

Volume

9,362

Today's Range

144.20

 - 

146.00

52 Week Range

106.19

 - 

154.00

As of on the SIX Swiss Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
145.00
Open
146.00
Volume
9,362
3M AVG Volume
0.15
Today's High
146.00
Today's Low
144.20
52 Week High
154.00
52 Week Low
106.19
Shares Out (MIL)
13.99
Market Cap (MIL)
1,007.70
Forward P/E
38.30
Dividend (Yield %)
1.91

Latest Developments

More

Bachem Holding Reports HY Sales Of 134.5 Million CHF

Bachem Holding Completes Of Capital Increase

Bachem Holding Sets Subscription And Placement Price At CHF 120.00/Shr

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About BACHEM HOLDING AG

Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.

Industry

Biotechnology & Drugs

Contact Info

Hauptstrasse 144

+41.61.9352333

http://www.bachem.com/

Key Stats

2.80 mean rating - 5 analysts
Sell
Hold
Buy
Revenue (MM, CHF)

2016

0.2K

2017

0.3K

2018

0.3K

2019(E)

0.3K
EPS (CHF)

2016

3.040

2017

3.080

2018

3.430

2019(E)

3.786
Price To Earnings (TTM)
38.74
Price To Sales (TTM)
3.29
Price To Book (MRQ)
4.86
Price To Cash Flow (TTM)
13.46
Total Debt To Equity (MRQ)
27.56
LT Debt To Equity (MRQ)
14.55
Return on Investment (TTM)
11.24
Return on Equity (TTM)
8.62

Latest News

BRIEF-Bachem Holding Reports HY Sales Of 134.5 Million CHF

* SALES OF 134.5 MILLION CHF AND SURGE IN OPERATING INCOME IN THE FIRST HALF

BRIEF-Bachem Holding Completes Of Capital Increase

* SHARE CAPITAL WILL BE INCREASED BY 400,000 NEW REGISTERED SHARES Source text - https://bit.ly/2VLl4zn Further company coverage: (Gdynia Newsroom)

BRIEF-Bachem Holding Sets Subscription And Placement Price At CHF 120.00/Shr

Bachem Holding AG: * SUBSCRIPTION AND PLACEMENT PRICE SET AT CHF 120.00/SHR * SUBSCRIPTION RATIO 34:1 * CAPITAL INCREASE OF UP TO 400,000 NEW REGISTERED SHARES Source text - https://bit.ly/2XHROXF Further company coverage: (Gdynia Newsroom)

BRIEF-Bachem Holding Reports FY 2018 Sales Of CHF 282.5 Mln

* FY 2018 OPERATING RESULT ROSE BY 8.3% TO 54.8 MILLION CHF AT EBIT LEVEL AND BY 8.9% TO 77.9 MILLION CHF AT EBITDA LEVEL

BRIEF-Bachem Holding H1 Net Income Up At 16.5 Million CHF

* 7.2% DECREASE IN NET SALES TO 110.9 MILLION CHF FOR FIRST HALF OF 2018 (H1 2017: 119.5 MILLION CHF)

BRIEF-Bachem Holding H1 net profit down to CHF 15.8 mln

* INCREASED ITS SALES IN THE FIRST HALF OF 2017 BY 5.3% TO A NEW RECORD HIGH OF 119.5 MILLION CHF (H1 2016: 113.4 MILLION CHF)

BRIEF-Cyxone starts collaboration with Bachem in Switzerland

* COOPERATION AGREEMENT LASTS FOR ABOUT A YEAR AND HAS A TOTAL BUDGET OF SEK 2.5 MILLION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Bachem Holding FY net income rose 29.4 pct to CHF 41.2 mln

* Full-year sales of 236.5 million Swiss francs ($237.33 million) (2015: 208.6 million francs, +13.4 percent in francs)

BRIEF-Bachem Holding renews supply contract with AstraZeneca

* Renews supply contract with AstraZeneca for the peptide active substance Goserelin

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up